BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28912140)

  • 1. Downregulation of
    Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
    Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
    [No Abstract]   [Full Text] [Related]  

  • 2. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
    Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
    Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
    Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
    Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer.
    Qu LL; He L; Zhao X; Xu W
    Int J Mol Med; 2015 May; 35(5):1266-72. PubMed ID: 25812680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
    Ye C; Shen Z; Wang B; Li Y; Li T; Yang Y; Jiang K; Ye Y; Wang S
    J Exp Clin Cancer Res; 2016 Dec; 35(1):187. PubMed ID: 27912775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1-C activates the TAK1 inflammatory pathway in colon cancer.
    Takahashi H; Jin C; Rajabi H; Pitroda S; Alam M; Ahmad R; Raina D; Hasegawa M; Suzuki Y; Tagde A; Bronson RT; Weichselbaum R; Kufe D
    Oncogene; 2015 Oct; 34(40):5187-97. PubMed ID: 25659581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer.
    Yang SS; Li XM; Yang M; Ren XL; Hu JL; Zhu XH; Wang FF; Zeng ZC; Li JY; Cheng ZQ; Liao WT; Ding YQ; Guan J; Liang L
    Br J Cancer; 2017 Oct; 117(8):1164-1175. PubMed ID: 28817833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.
    Bai F; Zhou H; Fu Z; Xie J; Hu Y; Nie S
    Biomed Pharmacother; 2018 Mar; 99():402-410. PubMed ID: 29367109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin.
    Agarwal A; Das K; Lerner N; Sathe S; Cicek M; Casey G; Sizemore N
    Oncogene; 2005 Feb; 24(6):1021-31. PubMed ID: 15592509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STX2 promotes colorectal cancer metastasis through a positive feedback loop that activates the NF-κB pathway.
    Wang Y; Xu H; Jiao H; Wang S; Xiao Z; Zhao Y; Bi J; Wei W; Liu S; Qiu J; Li T; Liang L; Ye Y; Liao W; Ding Y
    Cell Death Dis; 2018 May; 9(6):664. PubMed ID: 29855462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo.
    Zhou J; Zheng B; Ji J; Shen F; Min H; Liu B; Wu J; Zhang S
    Tumour Biol; 2015 May; 36(5):3301-8. PubMed ID: 25524577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer.
    Ou B; Zhao J; Guan S; Feng H; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Shen X; Zheng M; Lu A
    Oncotarget; 2016 Jul; 7(30):47637-47649. PubMed ID: 27356745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.
    Wen J; Liu X; Qi Y; Niu F; Niu Z; Geng W; Zou Z; Huang R; Wang J; Zou H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):428. PubMed ID: 31665064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation.
    Gao Y; Nan X; Shi X; Mu X; Liu B; Zhu H; Yao B; Liu X; Yang T; Hu Y; Liu S
    BMC Cancer; 2019 Jul; 19(1):685. PubMed ID: 31299935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
    Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
    Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation.
    Liang ZX; Liu HS; Xiong L; Yang X; Wang FW; Zeng ZW; He XW; Wu XR; Lan P
    Mol Cancer; 2021 Aug; 20(1):103. PubMed ID: 34412652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.